[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Melphalan and High Dose IV Vitamin C for Multiple Myeloma with Yogesh Jethava, MD, University of Iowa

Melphalan and High Dose IV Vitamin C for Multiple Myeloma with Yogesh Jethava, MD, University of Iowa image

Melphalan and High Dose IV Vitamin C for Multiple Myeloma with Yogesh Jethava, MD, University of Iowa

Podcast
event Apr 18, 2019 / 11:00AM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Yogesh Jethava, MD
University of Iowa, Holden Cancer Center 
Interview Date: April 18, 2019

Most myeloma patients are familiar with how the chemotherapy melphalan is used during stem cell transplant. It is typically used in high doses and remains the single most effective drug to kill myeloma, but has significant side effects. Dr. Yogesh Jethava of the University of Iowa joins us to share how his open clinical trial for relapsed or refractory myeloma patients (those who have failed proteasome inhibitors, immunomodulators or daratumumab) can use low doses of melphalan combined with high dose IV Vitamin C. Dr. Jethava shares two more upcoming studies (smoldering myeloma and older patients who are currently transplant ineligible) that will open soon. Learn more about this fascinating use of existing drugs in combination. 

Thanks to our episode sponsor

 

Schedule & Agenda

Event panelist Dr. Yogesh Jethava & Jenny Ahlstrom
11:00 AM
Discussion
Dr. Yogesh Jethava & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.